JP2019510047A5 - - Google Patents

Download PDF

Info

Publication number
JP2019510047A5
JP2019510047A5 JP2018550817A JP2018550817A JP2019510047A5 JP 2019510047 A5 JP2019510047 A5 JP 2019510047A5 JP 2018550817 A JP2018550817 A JP 2018550817A JP 2018550817 A JP2018550817 A JP 2018550817A JP 2019510047 A5 JP2019510047 A5 JP 2019510047A5
Authority
JP
Japan
Prior art keywords
vector
subject
gad65
vgat
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018550817A
Other languages
English (en)
Japanese (ja)
Other versions
JP6949867B2 (ja
JP2019510047A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/024285 external-priority patent/WO2017172606A1/en
Publication of JP2019510047A publication Critical patent/JP2019510047A/ja
Publication of JP2019510047A5 publication Critical patent/JP2019510047A5/ja
Application granted granted Critical
Publication of JP6949867B2 publication Critical patent/JP6949867B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018550817A 2016-03-28 2017-03-27 神経の過剰興奮を治療するための方法および組成物 Active JP6949867B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662314128P 2016-03-28 2016-03-28
US62/314,128 2016-03-28
PCT/US2017/024285 WO2017172606A1 (en) 2016-03-28 2017-03-27 Method and composition for treating neuronal hyper-excitability

Publications (3)

Publication Number Publication Date
JP2019510047A JP2019510047A (ja) 2019-04-11
JP2019510047A5 true JP2019510047A5 (https=) 2020-05-07
JP6949867B2 JP6949867B2 (ja) 2021-10-13

Family

ID=59966409

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018550817A Active JP6949867B2 (ja) 2016-03-28 2017-03-27 神経の過剰興奮を治療するための方法および組成物

Country Status (8)

Country Link
US (1) US11472859B2 (https=)
EP (1) EP3436427B1 (https=)
JP (1) JP6949867B2 (https=)
KR (1) KR102489437B1 (https=)
CN (1) CN108884022B (https=)
AU (1) AU2017241534A1 (https=)
CA (1) CA3018960C (https=)
WO (1) WO2017172606A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10688285B2 (en) 2015-01-30 2020-06-23 The Regents Of The University Of California Spinal subpial gene delivery system
AU2017241534A1 (en) 2016-03-28 2018-10-04 The Regents Of The University Of California Method and composition for treating neuronal hyper-excitability
CA3074587A1 (en) * 2017-09-08 2019-03-14 The Regents Of The University Of California Method and composition for treating neuropathic pain
GB201810301D0 (en) * 2018-06-22 2018-08-08 Evox Therapeutics Ltd Combinatorial gene therapy
CN113260317B (zh) 2019-01-10 2024-05-07 加利福尼亚大学董事会 软膜下递送系统和使用方法
USD963164S1 (en) 2020-01-09 2022-09-06 The Regents Of The University Of California Surgical needle
WO2025070749A1 (ja) * 2023-09-29 2025-04-03 田辺三菱製薬株式会社 脊髄又は脳の障害により引き起こされる疾患に伴う随伴症状の予防又は治療剤

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5292722A (en) 1992-11-06 1994-03-08 Brigham And Women's Hospital Intravenous solution that diminishes body protein loss
FR2705361B1 (fr) 1993-05-18 1995-08-04 Centre Nat Rech Scient Vecteurs viraux et utilisation en thérapie génique.
EP0705344B8 (en) 1993-06-24 2006-05-10 Advec Inc. Adenovirus vectors for gene therapy
SK282843B6 (sk) 1993-07-13 2002-12-03 Rhone-Poulenc Rorer S. A. Defektný rekombinantný adenovírus a farmaceutický prostriedok s jeho obsahom
WO1995013365A1 (en) 1993-11-09 1995-05-18 Targeted Genetics Corporation Generation of high titers of recombinant aav vectors
PT728214E (pt) 1993-11-09 2004-11-30 Ohio Med College Linhas celulares estaveis capazes de expressar o gene de replicacao do virus adeno-associado
WO1995016772A1 (en) 1993-12-14 1995-06-22 Cornell Research Foundation, Inc. Adenovirus gene expression system
FR2716893B1 (fr) 1994-03-03 1996-04-12 Rhone Poulenc Rorer Sa Virus recombinants, leur préparation et leur utilisation thérapeutique.
AUPM452094A0 (en) 1994-03-17 1994-04-14 University Of Queensland, The Waste treatment plant and process
US5643286A (en) 1994-06-24 1997-07-01 Cytotherapeutics, Inc. Microdrive for use in stereotactic surgery
CA2207927A1 (en) 1994-12-06 1996-06-13 Targeted Genetics Corporation Packaging cell lines for generation of high titers of recombinant aav vectors
US20020007145A1 (en) 1998-10-23 2002-01-17 Timothy Stivland Catheter having improved bonding region
CA2363254C (en) 1999-03-07 2009-05-05 Discure Ltd. Method and apparatus for computerized surgery
WO2002020753A2 (en) 2000-09-01 2002-03-14 Lexicon Genetics Incorporated Human gaba transporter protein and polynucleotides encoding the same
US7011647B2 (en) 2001-07-13 2006-03-14 Scimed Life Systems, Inc. Introducer sheath
ATE524121T1 (de) 2004-11-24 2011-09-15 Abdou Samy Vorrichtungen zur platzierung eines orthopädischen intervertebralen implantats
US20070213292A1 (en) 2005-08-10 2007-09-13 The Rockefeller University Chemically modified oligonucleotides for use in modulating micro RNA and uses thereof
KR20080007968A (ko) 2006-07-19 2008-01-23 연세대학교 산학협력단 Gad65를 발현하는 재조합 벡터를 포함하는 신경병증성통증 완화용 조성물
EP2066791B1 (en) 2006-10-03 2012-09-12 Genzyme Corporation Gene therapy for amyotrophic lateral sclerosis and other spinal cord disorders
CA2710969C (en) 2008-01-14 2016-02-09 I-V Access Technology, Inc. An apparatus for peripheral vascular access
EP2274041B1 (en) 2008-04-04 2016-06-08 The Cleveland Clinic Foundation Spinal platform for delivering a therapeutic agent to a spinal cord target
WO2010071832A1 (en) 2008-12-19 2010-06-24 Nationwide Children's Hospital Delivery of polynucleotides across the blood brain barrier using recombinant aav9
WO2011057171A1 (en) 2009-11-08 2011-05-12 Quark Pharmaceuticals, Inc. METHODS FOR DELIVERY OF siRNA TO THE SPINAL CORD AND THERAPIES ARISING THEREFROM
DK2621282T3 (da) 2010-09-28 2020-05-04 Univ California Gaba-agonister i behandlingen af forstyrrelser forbundet med metabolisk syndrom og gaba-kombinationer i behandling eller profylakse af type i diabetes
US20120310140A1 (en) 2010-12-01 2012-12-06 Spinal Modulation, Inc. Directed delivery of agents to neural anatomy
JP6188728B2 (ja) 2012-02-07 2017-08-30 グローバル・バイオ・セラピューティクス・インコーポレイテッドGlobal Bio Therapeutics,Inc. 核酸送達の区画化方法ならびにその組成物および使用
EP2897670A4 (en) 2012-09-24 2016-05-25 Univ California INJECTION SYSTEM FOR BACKMARK WITH PULSATION SUPPRESSION
WO2014116652A2 (en) 2013-01-23 2014-07-31 The Regents Of The University Of California Method and composition for treating spasticity
GB201308917D0 (en) 2013-05-17 2013-07-03 Renishaw Plc Delivery
US10688285B2 (en) 2015-01-30 2020-06-23 The Regents Of The University Of California Spinal subpial gene delivery system
US20180008727A1 (en) 2015-01-30 2018-01-11 The Regents Of The University Of California Spinal subpial gene delivery system
US20170151416A1 (en) * 2015-12-01 2017-06-01 Invivo Therapeutics Corporation Methods and Systems for Delivery of a Trail of a Therapeutic Substance into an Anatomical Space
AU2017241534A1 (en) 2016-03-28 2018-10-04 The Regents Of The University Of California Method and composition for treating neuronal hyper-excitability

Similar Documents

Publication Publication Date Title
JP2019510047A5 (https=)
US12246072B2 (en) Gene therapy for the treatment of CNGB1-linked retinitis pigmentosa
JP2021502060A5 (https=)
JP2022500066A5 (https=)
JP2015523379A5 (https=)
JP2020508685A5 (https=)
RU2018112506A (ru) Лечение пигментного ретинита
JP2020518268A5 (https=)
JP2022531861A5 (https=)
RU2019100525A (ru) Векторная система на основе аденоассоциированного вируса
JP2022511453A5 (https=)
JP2022514465A5 (https=)
JP2018533976A5 (https=)
JP2023549357A5 (https=)
CN108884022A (zh) 用于治疗神经元的过度兴奋的方法和组合物
JP2020503265A5 (https=)
JP2020535804A5 (https=)
JP2017523239A5 (https=)
CA3110282A1 (en) Fasl immunomodulatory gene therapy compositions and methods for use
JP2025513066A5 (https=)
Dong et al. Cloning and characterisation of two natural killer enhancing factor genes (NKEF-A and NKEF-B) in pufferfish, Tetraodon nigroviridis
IL308645A (en) Viral vectors comprising rdh12 coding regions and methods of treating retinal dystrophies
JP2022529500A5 (https=)
JP2022548800A5 (https=)
JP2024503091A5 (https=)